Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment

Paper deals with the content of CD95+-cells in the blood of patients with ovarian cancer and benign tumors. Found that patients with a malignant process and low CD95+-cells before treatment and during chemotherapy have a poor survival. The initial increase in the relative level CD95+- cells has no e...

Full description

Bibliographic Details
Main Authors: N. G. Kormosh, T. N. Zabotina
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/45